Drusen proteome analysis: An approach to the etiology of age-related macular degeneration
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index; 3 of the 17 sources its claims cite were checked for support.
Abstract
Drusen are extracellular deposits that accumulate below the retinal pigment epithelium on Bruch's membrane and are risk factors for developing age-related macular degeneration (AMD). The progression of AMD might be slowed or halted if the formation of drusen could be modulated. To work toward a molecular understanding of drusen formation, we have developed a method for isolating microgram quantities of drusen and Bruch's membrane for proteome analysis. Liquid chromatography tandem MS analyses of drusen preparations from 18 normal donors and five AMD donors identified 129 proteins. Immunocytochemical studies have thus far localized ≈16% of these proteins in drusen. Tissue metalloproteinase inhibitor 3, clusterin, vitronectin, and serum albumin were the most common proteins observed in normal donor drusen whereas crystallin was detected more frequently in AMD donor drusen. Up to 65% of the proteins identified were found in drusen from both AMD and normal donors. However, oxidative protein modifications were also observed, including apparent crosslinked species of tissue metalloproteinase inhibitor 3 and vitronectin, and carboxyethyl pyrrole protein adducts. Carboxyethyl pyrrole adducts are uniquely generated from the oxidation of docosahexaenoate-containing lipids. By Western analysis they were found to be more abundant in AMD than in normal Bruch's membrane and were found associated with drusen proteins. Carboxymethyl lysine, another oxidative modification, was also detected in drusen. These data strongly support the hypothesis that oxidative injury contributes to the pathogenesis of AMD and suggest that oxidative protein modifications may have a critical role in drusen formation.
Overview
CoChat Summary
TL;DR
This study developed a method to isolate microgram quantities of drusen and analyzed their proteome by LC MS/MS, identifying 129 proteins from normal and AMD donor eyes. It reports oxidative protein modifications, especially carboxyethyl pyrrole adducts, that are more abundant in AMD Bruch’s membrane, supporting a role for oxidative injury in AMD pathogenesis.
Key findings
- LC MS/MS of drusen preparations from 18 normal donors and five AMD donors identified 129 proteins: 107 from normal donors and 62 from AMD donors. About 38% (41/107) of normal-donor proteins were also found in AMD donors, and 65% (42/62) of AMD-donor proteins were found in normal donors; 21 of 62 AMD proteins (≈33%) were not observed in normal donor drusen.
- TIMP3, clusterin, vitronectin, and serum albumin were the most common proteins in normal donor drusen, detectable in up to 80% of tissues from the 18 normal donors and 60% of drusen preparations from the five AMD donors. Crystallin was detected more frequently in AMD donor drusen.
- Immunocytochemistry localized ≈16% (21/129) of identified proteins in drusen.
- Oxidative modifications were observed, including apparent crosslinked species of TIMP3 and vitronectin and carboxyethyl pyrrole (CEP) protein adducts. By Western analysis, CEP immunoreactivity was present in 9 of 11 AMD samples versus 2 of 11 age-matched controls (Fischer’s test, P = 0.004 single-sided); carboxymethyl lysine was also detected in drusen.
Methods
- Human donor eyes from 29 normal and 16 AMD donors, ages 56–98 years, were used. Drusen isolation and protein identification used 23 eyes (18 normal, five AMD); Western analyses used 22 eyes (11 normal, 11 AMD). Eyes were enucleated 1.5–7 h after death and frozen.
- Drusen were manually isolated from Bruch’s membrane, proteins were extracted, trypsin-digested, and analyzed by liquid chromatography tandem MS (LC MS/MS) with database searching. Immunocytochemistry and Western analysis were used to confirm drusen localization and detect oxidative modifications.
- For CEP Western analysis, Bruch’s membrane/RPE/choroid from AMD and age- and gender-matched normal donors was subjected to SDS/PAGE (≈20 µg protein per lane) and probed with anti-CEP antibodies.
Limitations
- The paper states that mass spectrometric analyses did not measure protein abundance; the number of proteins identified per drusen preparation varied from 0 to 39 and averaged 19. It also notes that some identified proteins may be soluble contaminants or, as with annexin II, localized to RPE tissue adhering to drusen, and that additional AMD donors are required to establish the significance of the crystallin observation.
- The paper states that whether any drusen protein is uniquely associated with AMD remains to be determined.
- Evident from the text: the AMD proteomic group was small (five donors), many isolated drusen were from far peripheral locations, and immunocytochemical confirmation covered only ≈16% of identified proteins.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 1 Not valid · 8 Not checked · 29 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Among the nine identified immunopositive proteins were albumin and 𝛂 1-antitrypsin, both of which were detected in drusen by LC MS ∕ MS (Table 3) and immunocytochemistry (14).”
What the sources say
- Disputedcites [14] matched to “Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease” (2000) sourceExperimental — accuracy not yet measured
Our copy of Mullins et al. (2000) directly contradicts the attributed point: in the Immunohistochemistry section it states that 'Antibodies directed against human serum albumin and haptoglobin bound strongly to the choroidal stroma, but not to hard or soft drusen,' and Table 1 scores Albumin as negative for drusen (figure legend for panel J repeats that labeling was not generally observed with albumin antibodies). Alpha-1-antitrypsin is likewise not presented as an identified drusen component — the same section reports 'Weak and/or inconsistent drusen labeling of antibodies directed against the protease inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin,' and Table 1 lists it as negative with only rare variable reactions. The proteins the paper does identify in all drusen phenotypes are amyloid P component, apolipoprotein E, immunoglobulin light chains, Factor X and complement C5/C5b-9 (Abstract; Immunohistochemistry), and the study contains no carboxyethylpyrrole/CEP-adduct work and no LC-MS/MS data. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The multiple, higher mass electrophoretic components containing these proteins suggest the presence of covalent crosslinks, protein modifications that can be caused by reactive lipid and carbohydrate oxidation products (22, 23).”
What the sources say
- Partly supportedcites [22] Friguet, B., Stadtman, E. R. & Szweda, L. I. (1994) J. Biol. Chem. 269, 21639-21643. sourceExperimental — accuracy not yet measured
Friguet et al. (1994) directly support the lipid-oxidation half of what the paired citation is offered for: the Cross-linking of Glu-6-PDH by HNE section (Fig. 1) shows progressive appearance of higher-mass multimeric (dimeric, tetrameric) protein on SDS-gel filtration and SDS-gel electrophoresis after exposure to the lipid peroxidation product HNE, i.e. covalent cross-links, and the Discussion/Abstract state this explicitly. Our copy contains no passage attributing cross-linking to carbohydrate oxidation products (searched: carbohydrate/glycation cross-linking — only lipid peroxidation products HNE and malondialdehyde are discussed), so that half of the claim is not supported by this source; the cross-links shown are also formed in vitro on a heterologous bacterial model enzyme at 5 mM HNE, with the Discussion conceding basal in vivo HNE concentrations are ~3 orders of magnitude lower. The citing authors' own observation of higher-mass electrophoretic components containing TIMP-3 and vitronectin is not something this paper reports. (LLM, conf=0.70)
- Partly supportedcites [23] Elgawish, A., Glomb, M., Friedlander, M. & Monnier, V. M. R. (1996) J. Biol. Chem. 271, 12964-12971. sourceExperimental — accuracy not yet measured
Our copy of Elgawish et al. (1996) supports the carbohydrate-oxidation half of the attributed point: the Introduction (p.1) notes that 'metal-catalyzed glucose autoxidation may be more important than glycation for generation of fluorescent protein adducts and cross-links' and that deoxyosones/glyoxal and 'reactive ketoaldehydes might be responsible for collagen cross-linking', and the Discussion proposes an H2O2- and Amadori-product-driven covalent lysine-lysine cross-link. The lipid-oxidation half is not asserted by this paper: in the Discussion it appears only as an alternative model ('H2O2 ... could catalyze collagen cross-linking, e.g. through lipid peroxidation (44)'), which the authors immediately discount for their system ('Lipid peroxidation, however, is unlikely to be involved since many studies have shown that it is not preventable by catalase'). The paper also reports no electrophoretic high-mass protein components (its cross-linking readouts are tendon breaking time, linked fluorescence, CML, pentosidine), so it does not address the TIMP-3/vitronectin observation itself. (LLM, conf=0.72)
hedgedstates an associationSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Tissue metalloproteinase inhibitor 3, clusterin, vitronectin, and serum albumin were the most common proteins observed in normal donor drusen whereas crystallin was detected more frequently in AMD donor drusen.”
- Also stated in: § Results · hedged
“Tissue metalloproteinase inhibitor 3 (TIMP3), clusterin, vitronectin and serum albumin appear to be common drusen proteins, detectable in up to 80% of the tissues from the 18 normal donors”
plainn = 18- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · hedged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By Western analysis they were found to be more abundant in AMD than in normal Bruch's membrane and were found associated with drusen proteins.”
- Also stated in: § Results · plain
“Western results (Fig. 3) revealed more frequent CEP immunoreactivity among the AMD samples than in the normal controls. Specifically, nine of the 11 AMD samples were immunopositive whereas only two of the 11 age-matched controls were CEP immunoreactive. Statistically these CEP immunoreactivity results are significantly different between AMD and normal donors (Fischer's test, P value = 0.004 single”
plainstates an associationn = 11- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Immunocytochemical studies have thus far localized ≈ 16% of these proteins in drusen.”
- Also stated in: § Discussion · plain
“To verify drusen localization, immunocytochemical studies are ongoing, and to date 21 of the identified proteins (16%) have been confirmed as drusen components in our laboratories and elsewhere.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
20 more claims
Create a free account to see all 39 claims and to verify the 14 references still open.
- Probably not a substantial claim. 9
- It may state two separate claims as one. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Biochemical analysis of drusen has identified glycoconjugates and components found in atherosclerotic plaques including vitronectin, apolipoprotein B and E, alpha-crystallin, complement proteins, and lipids (32, 106, 115).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In an AMD patient’s outer retina and plasma, there are more CEP-modified proteins when compared to age-matched controls (Crabb et al., 2002).”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Serum albumin is one of the major proteins modified with CEP”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Biochemical analysis of drusen have indeed resulted in identification of complement components and inflammatory modulators [2–8].”
From CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD (2005) · cites this paper as [8]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“immunize mice with CEP-modified mouse serum albumin, generating a strong immunologic response against endogenous CEP adducts in the outer retina”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“65% (42 ∕ 62) of the proteins identified from AMD donor drusen were found in tissues from normal donors.”
Reported 65 · recomputed 67.741935
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discussion
“About 38% (41 ∕ 107) of the proteins identified from normal donor drusen were also found in drusen from AMD donors”
§ Discussion
“65% (42 ∕ 62) of the proteins identified from AMD donor drusen were found in tissues from normal donors”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Twenty-one of the 62 proteins detected in drusen from AMD tissue ( ≈ 33%) were not observed in normal donor drusen (Table 3).”
Reported 21 · recomputed 22
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
The Role of Oxidative Stress in the Pathogenesis of Age-Related Macular Degeneration
Beatty, S., Koh, H.-H., Phil, M., Henson, D., & Boulton, M. (2000) · Survey of Ophthalmology · doi:10.1016/s0039-6257(00)00140-5 · Cited by 2,051
Allikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Chemistry and metabolism of lipids in the vertebrate retina
Fliesler, A. J., & Anderson, R. E. (1983) · Progress in Lipid Research · doi:10.1016/0163-7827(83)90004-8 · Cited by 1,052
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
Ahmed, M. U., Thorpe, S. R., & Baynes, J. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89188-3 · Cited by 864
Identification of the gene responsible for Best macular dystrophy
Petrukhin, K., Koisti, M. J., Bakall, B., Li, W., Xie, G., Marknell, T., Sandgren, O., Forsman, K., Holmgren, G., Andreasson, S., et al. (1998) · Nature Genetics · doi:10.1038/915 · Cited by 689
Positional cloning of the gene associated with X-linked juvenile retinoschisis
Sauer, C. G., Gehrig, A., Warneke-Wittstock, R., Marquardt, A., Ewing, C. C., Gibson, A., Lorenz, B., Jurklies, B., & Weber, B. H. F. (1997) · Nature Genetics · doi:10.1038/ng1097-164 · Cited by 497
Research works printed but not linked: 3
- Midena E., Deglii Angeli, C., Blarzino, M., Valenti, M. & Segato, T. (1997) Invest. Ophthalmol. Visual Sci.38,469-477.9040480
- Kamei M. & Hollyfield, J. E. (1999) Invest. Ophthalmol. Visual Sci.40,2367-2375.10476804
- Handa, J. T., Verzijl, N., Matsunaga, H., Aotaki-Keen, A., Lutty, G. A., te Koppele, J. M., Miyata, T. & Hjelmeland, L. M. (1999) Invest. Ophthalmol. Visual Sci. 40, 775-779.
Cited by
Items 101–200 of 1,000
Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1
Hoppe, G., Talcott, K. E., Bhattacharya, S. K., Crabb, J. W., & Sears, J. E. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.07.020 · Cited by 191
Self-citationZareparsi, S., Buraczynska, M., Branham, K. E. H., Shah, S., Eng, D., Li, M., Pawar, H., Yashar, B. M., Moroi, S. E., Lichter, P. R., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi154 · Cited by 190
“Extensive studies suggest that compromised RPE function, local inflammation, oxidative damage and altered cholesterol/lipid metabolism contribute to AMD pathogenesis (4,5,36,39,54,55).”
BackgroundSomasundaran, S., Constable, I. J., Mellough, C. B., & Carvalho, L. S. (2020) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.13834 · Cited by 190
“After a hypothesis by Johnson et al on the potential of the immune complex to be involved in the formation of drusen, immunocytochemical evidence showed components of the complement system,(26) including C3, C5 and C9, to be present in drusen of AMD patients.(27) Additionally, many studies show that drusen deposits ar…”
BackgroundNordgaard, C. L., Karunadharma, P. P., Feng, X., Olsen, T. W., & Ferrington, D. A. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1352 · Cited by 188
Hata, M., Andriessen, E. M. M. A., Hata, M., Diaz-Marin, R., Fournier, F., Crespo-Garcia, S., Blot, G., Juneau, R., Pilon, F., Dejda, A., et al. (2023) · Science · doi:10.1126/science.abj8894 · Cited by 187
Cano, M., Thimmalappula, R., Fujihara, M., Nagai, N., Sporn, M., Wang, A. L., Neufeld, A. H., Biswal, S., & Handa, J. T. (2010) · Vision Research · doi:10.1016/j.visres.2009.08.018 · Cited by 184
Abecasis, G. R., Yashar, B. M., Zhao, Y., Ghiasvand, N. M., Zareparsi, S., Branham, K. E. H., Reddick, A. C., Trager, E. H., Yoshida, S., Bahling, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/382786 · Cited by 182
“Oxidative stress and immune-mediated processes are believed to contribute to AMD pathogenesis (Cai et al. 2000; Hageman et al. 2001; Crabb et al. 2002; Johnson et al. 2002; Ambati et al. 2003); however, precise molecular events have not yet been elucidated.”
BackgroundBarker, F. M., Snodderly, D. M., Johnson, E. J., Schalch, W., Koepcke, W., Gerss, J., & Neuringer, M. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5898 · Cited by 182
“Other evidence of potentially negative effects of n–3 fatty acids comes from studies showing that oxidative products of DHA form protein adducts that are elevated in AMD patients’ plasma and RPE.(61) On the other hand, several recent studies provide rationales for antioxidative, antiinflammatory, and neuroprotective a…”
BackgroundInfluentialProtein Oxidation in Aging: Does It Play a Role in Aging Progression?
Reeg, S., & Grune, T. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6062 · Cited by 181
“Oxidative protein modifications were found in retina (139) and drusen (28).”
BackgroundOxidation and age-related macular degeneration: insights from molecular biology
Khandhadia, S., & Lotery, A. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239941000164x · Cited by 181
Nature and nurture- genes and environment- predict onset and progression of macular degeneration
Sobrin, L., & Seddon, J. M. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.12.004 · Cited by 178
“, 2001) and other age-related diseases, including amyloid P component, complement proteins, and carboxyethyl pyrrole adducts which are generated by the oxidation of lipids (Crabb et al., 2002; Mullins et al., 2000).”
Langer, H. F., Chung, K.-J., Orlova, V. V., Choi, E. Y., Kaul, S., Kruhlak, M. J., Alatsatianos, M., DeAngelis, R. A., Roche, P. A., Magotti, P., et al. (2010) · Blood · doi:10.1182/blood-2010-01-261503 · Cited by 176
Oxidative Stress in Age-Related Macular Degeneration: Nrf2 as Therapeutic Target
Bellezza, I. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01280 · Cited by 173
“The main risk factors for the development of AMD are aging, ethnicity, genetics and environmental insults, including cigarette smoking, high fat diet and light-induced photooxidative reactions (Organisciak and Vaughan, 2010; Datta et al., 2017).”
InfluentialRudolf, M., Clark, M. E., Chimento, M. F., Li, C.-M., Medeiros, N. E., & Curcio, C. A. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1466 · Cited by 173
Panigrahi, S., Ma, Y., Hong, L., Gao, D., West, X. Z., Salomon, R. G., Byzova, T. V., & Podrez, E. A. (2013) · Circulation Research · doi:10.1161/circresaha.112.274241 · Cited by 172
Self-citationBasal deposits and drusen in eyes with age-related maculopathy: Evidence for solid lipid particles
Curcio, C. A., Presley, J. B., Millican, C. L., & Medeiros, N. E. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2004.09.017 · Cited by 171
Abokyi, S., To, C.-H., Lam, T. T., & Tse, D. Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7901270 · Cited by 167
“Donor eyes with AMD showed a higher level of the carboxyethylpyrrole (CEP) in the BrM compared to normal eyes [43].”
BackgroundOxidative stress, innate immunity, and age-related macular degeneration
X. Shaw, P., 1 Department of Ophthalmology and Shiley Eye Institute, U. O. C. S. D., Stiles, T., Douglas, C., Ho, D., Fan, W., Du, H., & Xiao, X. (2016) · AIMS Molecular Science · doi:10.3934/molsci.2016.2.196 · Cited by 165
“The strong association of complement pathway genes with AMD susceptibility [125] and the presence of complement proteins in drusen indicate that AMD is likely, at least in part, a chronic inflammatory disease involving abnormal regulation of complement and immune system [25,126-131].”
BackgroundLiu, B., Wei, L., Meyerle, C., Tuo, J., Sen, H. N., Li, Z., Chakrabarty, S., Agron, E., Chan, C.-C., Klein, M. L., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-111 · Cited by 164
“The drusen of AMD donor eyes contain almost all molecules of the alternative complement pathway, including CFH, C3, C5, C3a, C5a, and the membrane attack complex (MAC) [35-37].”
BackgroundImmunopathological aspects of age-related macular degeneration
Patel, M., & Chan, C.-C. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0112-9 · Cited by 164
“A variety of other studies have similarly demonstrated the presence of immune complexes, complement, and/or complement regulatory proteins in drusen and in nearby RPE [20–23].”
BackgroundUmeda, S., Suzuki, M. T., Okamoto, H., Ono, F., Mizota, A., Terao, K., Yoshikawa, Y., Tanaka, Y., & Iwata, T. (2005) · The FASEB Journal · doi:10.1096/fj.04-3525fje · Cited by 164
“Twenty of the identified proteins had been previously found to be components of drusen in AMD (indicated by bold letters in Table 3) (23).”
BackgroundInfluentialRetinal ultrastructure of murine models of dry age-related macular degeneration (AMD)
Ramkumar, H. L., Zhang, J., & Chan, C.-C. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.02.002 · Cited by 163
“In an AMD patient’s outer retina and plasma, there are more CEP-modified proteins when compared to age-matched controls (Crabb et al., 2002).”
BackgroundInfluentialRetinal pigment epithelial cell necroptosis in response to sodium iodate
Hanus, J., Anderson, C., Sarraf, D., Ma, J., & Wang, S. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.54 · Cited by 163
Lin, H., Xu, H., Liang, F.-Q., Liang, H., Gupta, P., Havey, A. N., Boulton, M. E., & Godley, B. F. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6163 · Cited by 163
Tan, A. C. S., Pilgrim, M. G., Fearn, S., Bertazzo, S., Tsolaki, E., Morrell, A. P., Li, M., Messinger, J. D., Dolz‐Marco, R., Lei, J., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat4544 · Cited by 166
Retinal Pigment Epithelium Lipofuscin Proteomics
Ng, K.-P., Gugiu, B., Renganathan, K., Davies, M. W., Gu, X., Crabb, J. S., Kim, S. R., Różanowska, M. B., Bonilha, V. L., Rayborn, M. E., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700525-mcp200 · Cited by 162
Self-citationFundus autofluorescence imaging
Schmitz-Valckenberg, S., Pfau, M., Fleckenstein, M., Staurenghi, G., Sparrow, J. R., Bindewald-Wittich, A., Spaide, R. F., Wolf, S., Sadda, S. R., & Holz, F. G. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100893 · Cited by 144
Complement factor H in AMD: Bridging genetic associations and pathobiology
Toomey, C. B., Johnson, L. V., & Bowes Rickman, C. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.09.001 · Cited by 161
“In addition, other complement-regulatory molecules, including vitronectin and clusterin, are also prevalent in drusen (Crabb et al., 2002; Hageman et al., 1999; Hawse et al., 2003; Jenne et al., 1991; Milis et al., 1993).”
BackgroundInfluentialDementia of the eye: the role of amyloid beta in retinal degeneration
Ratnayaka, J. A., Serpell, L. C., & Lotery, A. J. (2015) · Eye · doi:10.1038/eye.2015.100 · Cited by 153
Klenotic, P. A., Munier, F. L., Marmorstein, L. Y., & Anand-Apte, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403026200 · Cited by 155
Proteomics Reveal Cochlin Deposits Associated with Glaucomatous Trabecular Meshwork
Bhattacharya, S. K., Rockwood, E. J., Smith, S. D., Bonilha, V. L., Crabb, J. S., Kuchtey, R. W., Robertson, N. G., Peachey, N. S., Morton, C. C., & Crabb, J. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411233200 · Cited by 160
Self-citationSoluble and Mature Amyloid Fibrils in Drusen Deposits
Isas, J. M., Luibl, V., Johnson, L. V., Kayed, R., Wetzel, R., Glabe, C. G., Langen, R., & Chen, J. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4207 · Cited by 153
“Many protein and lipid constituents of drusen are similar to those found in deposits characteristic of other age-related degenerative disorders such as Alzheimer disease (AD) and other amyloid diseases.(1,2) These include amyloid (A ), vitronectin, amyloid P, apolipoprotein E, and inflammatory mediators such as acute…”
Schlanitz, F. G., Baumann, B., Kundi, M., Sacu, S., Baratsits, M., Scheschy, U., Shahlaee, A., Mittermüller, T. J., Montuoro, A., Roberts, P., et al. (2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-308422 · Cited by 154
“18 22 23 The Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) reported a spontaneous regression of drusen area in 31.2% of eyes after 5 years.”
BackgroundInfluentialYuan, X., Gu, X., Crabb, J. S., Yue, X., Shadrach, K., Hollyfield, J. G., & Crabb, J. W. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900523-mcp200 · Cited by 156
“As found for drusen (7), the quantified proteins were derived from many different cell types, including the choroid; red and white blood cell proteins; and other proteins present in the circulation.”
BackgroundMethodInfluentialSelf-citationDecanini, A., Nordgaard, C. L., Feng, X., Ferrington, D. A., & Olsen, T. W. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.12.006 · Cited by 157
Vavvas, D. G., Daniels, A. B., Kapsala, Z., Goldfarb, J. W., Ganotakis, E. S., Loewenstein, J. I., YOUNG, L. H. Y., Gragoudas, E. S., Eliott, D., Kim, I. K., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.01.033 · Cited by 164
“Inmany studies, drusen sampled for analysis are not confined to the macula; this is important to note because peripheral drusen (which can differ from macular drusen) may predominate (Crabb, 2014; Crabb et al., 2002).”
BackgroundLi, C.-M., Chung, B. H., Presley, J. B., Malek, G., Zhang, X., Dashti, N., Li, L., Chen, J., Bradley, K., Kruth, H. S., et al. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0034 · Cited by 150
Schnichels, S., Paquet‐Durand, F., Löscher, M., Tsai, T., Hurst, J., Joachim, S. C., & Klettner, A. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100880 · Cited by 161
Oxidative Stress and Antioxidants in Age-Related Macular Degeneration
Kushwah, N. S., Bora, K., Maurya, M., Pavlovich, M. C., & Chen, J. (2023) · Antioxidants · doi:10.3390/antiox12071379 · Cited by 163
Oxidative damage in age-related macular degeneration.
Shen, J., Dong, A., Hackett, S. F., Bell, W. R., Green, W. R., & Campochiaro, P. A. (2007) · PubMed · doi:10.14670/hh-22.1301 · Cited by 150
“Other techniques, such as proteomics, suggest that oxidized proteins occur in drusen and RPE (Crabb et al., 2002), so it is likely that genetic defects that result in susceptibility to oxidative damage in the RPE, but not generalized damage throughout the retina, may also result in a phenotype that…”
BackgroundInfluentialHow does the macula protect itself from oxidative stress?
Handa, J. T. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.03.006 · Cited by 154
“In addition, CEP is found in drusen of AMD patients (Crabb et al., 2002).”
BackgroundThe pathogenic role of Maillard reaction in the aging eye
Nagaraj, R. H., Linetsky, M. D., & Stitt, A. W. (2010) · Amino Acids · doi:10.1007/s00726-010-0778-x · Cited by 164
Wu, Y., Yanase, E., Feng, X., Siegel, M. M., & Sparrow, J. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913112107 · Cited by 149
Bertram, K. M., Baglole, C. J., Phipps, R. P., & Libby, R. T. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00126.2009 · Cited by 146
“Subsequent loss of RPE cells due to oxidative stress caused by cigarette smoke exposure may underlie AMD pathogenesis and/or contribute to disease progression (16, 21, 30, 59).”
BackgroundGross, J. M., Perkins, B. D., Amsterdam, A., Egaña, A., Darland, T., Matsui, J. I., Sciascia, S., Hopkins, N., & Dowling, J. E. (2005) · Genetics · doi:10.1534/genetics.104.039727 · Cited by 148
“A hallmark of AMD progression is the accumulation of drusen, a storage body composed mainly of undegraded photoreceptor outer segment lipids (Feeney-Burns et al., 1980; Crabb et al., 2002).”
BackgroundMcKay, G. J., Patterson, C. C., Chakravarthy, U., Dasari, S., Klaver, C. C., Vingerling, J. R., Ho, L., de Jong, P. T. V. M., Fletcher, A. E., Young, I. S., et al. (2011) · Human Mutation · doi:10.1002/humu.21577 · Cited by 151
“In addition, the positively charged ε4 haplotype has been proposed to improve permeability of Bruch’s membrane, for lipid transport and reducing debris accumulation associated with drusen formation [Crabb et al., 2002; Souied et al., 1998].”
BackgroundLiu, A., Chang, J., Lin, Y., Shen, Z., & Bernstein, P. S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m007518 · Cited by 151
Regulatory role of HIF-1α in the pathogenesis of age-related macular degeneration (AMD)
Arjamaa, O., Nikinmaa, M., Salminen, A., & Kaarniranta, K. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.06.002 · Cited by 165
Nordgaard, C. L., Berg, K. M., Kapphahn, R. J., Reilly, C., Feng, X., Olsen, T. W., & Ferrington, D. A. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0976 · Cited by 149
(2012) · PubMed Central · Cited by 150
Hecker, L. A., Edwards, A. O., Ryu, E., Tosakulwong, N., Baratz, K. H., Brown, W. L., Issa, P. C., Scholl, H. P., Pollok-Kopp, B., Schmid-Kubista, K. E., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp472 · Cited by 147
“Early AMD is characterized by the accumulation of inflammatory proteins, lipids and byproducts of the visual cycle in and under the retina (8,15,16).”
BackgroundShaw, P. X., Zhang, L., Zhang, M., Du, H., Zhao, L., Lee, C., Grob, S., Lim, S. L., Hughes, G., Lee, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121309109 · Cited by 148
“In addition, oxidation-modified proteins and lipids have been detected in drusen and Bruch’s membrane using Western blot analysis and immunohistochemistry (16).”
BackgroundRabbit Models of Ocular Diseases: New Relevance for Classical Approaches
Zernii, E. Y., Baksheeva, V. E., Иомдина, Е. Н., Averina, O. A., Permyakov, S. E., Philippov, P. P., Zamyatnin, A. A., & Senin, I. I. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666151110124957 · Cited by 156
Nowak, J. Z. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71005-3 · Cited by 165
“In AMD patients, the serum levels of CEP-protein adducts and anti-CEP-autoantibodies were so pronounced that they were proposed to serve an early biomarker of this retina disease [13, 27, 62].”
BackgroundSystemic and ocular fluid compounds as potential biomarkers in age-related macular degeneration
Kersten, E., Paun, C. C., Schellevis, R. L., Hoyng, C. B., Delcourt, C., Lengyel, I., Pető, T., Ueffing, M., Klaver, C. C. W., Dammeier, S., et al. (2017) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2017.05.003 · Cited by 161
“In addition, albumin is one of the most common proteins found in drusen.(63) A few studies measured serum albumin in AMD patients and controls.”
BackgroundAge-related Macular Degeneration: Genetic and Environmental Factors of Disease
Chen, Y., Bedell, M., & Zhang, K. (2010) · Molecular Interventions · doi:10.1124/mi.10.5.4 · Cited by 162
Retinal microglia: Functions and diseases
Fan, W., Huang, W., Chen, J., Li, N., Mao, L., & Hou, S. (2022) · Immunology · doi:10.1111/imm.13479 · Cited by 163
“A list of complement proteins was found to be enriched in the AMDaffected eye, including C1q, C3, C3a, C3b, C5a and CFH [43].”
BackgroundInfluentialMechanism of Inflammation in Age-Related Macular Degeneration
Parmeggiani, F., Romano, M. R., Costagliola, C., Semeraro, F., Incorvaia, C., D’Angelo, S., Perri, P., De Palma, P., De Nadai, K., & Sebastiani, A. (2012) · Mediators of Inflammation · doi:10.1155/2012/546786 · Cited by 135
Zarbin, M. A., & Rosenfeld, P. J. (2010) · Retina · doi:10.1097/iae.0b013e3181f57e30 · Cited by 140
“Advanced glycation end products occur in soft drusen, basal laminar and basal linear deposits, and the cytoplasm of RPE cells associated with choroidal neovascularization (CNV).(5,6) Carboxymethyl lysine is present in drusen and CNV(5,7) as are carboxyethyl pyrrole protein adducts.”
BackgroundRole of Oxidative Stress in Retinal Disease and the Early Intervention Strategies: A Review
Wang, J., Li, M., Geng, Z., Khattak, S., Ji, X., Wu, D., & Dang, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7836828 · Cited by 142
“(1) Cigarette smoking has been shown experimentally to be directly linked to the development of AMD and is a major risk factor in epidemiological studies [46, 47].”
Inflammaging in Skin and Other Tissues - The Roles of Complement System and Macrophage
Zhuang, Y., & Lyga, J. (2014) · Inflammation & Allergy-Drug Targets · doi:10.2174/1871528113666140522112003 · Cited by 132
“The composition of the drusen includes cell debris, lipid, lipoprotein and complement components, among others [21, 23].”
BackgroundDNA Methylation Is Associated with Altered Gene Expression in AMD
Hunter, A., Spechler, P. A., Cwanger, A., Song, Y., Zhang, Z., Ying, G.-S., Hunter, A. K., deZoeten, E., & Dunaief, J. L. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8449 · Cited by 134
“There is an increase in x-(2-carboxyethyl)pyrrole protein adducts secondary to oxidation of DHA-containing lipids in the retinas in AMD versus controls.(15,16) These oxidative insults cause an accumulation of free radical by-products.”
BackgroundAge-related macular degeneration and the aging eye
Harris, A., & Wirostko (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s2777 · Cited by 166
“Furthermore, it is postulated that the development of drusen is most likely a selective and active process than a passive accumulation of proteins and lipids (Crabb et al 2002).”
Thompson, R. B., Reffatto, V., Bundy, J. G., Kortvely, E., Flinn, J. M., Lanzirotti, A., Jones, E. A., McPhail, D. S., Fearn, S., Boldt, K., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413347112 · Cited by 128
“A feature of the aging retina is the deposition of proteins (1) and lipids (2) external to the retinal pigment epithelium (RPE), leading to the formation of sub-RPE deposits that can be focal (drusen) or diffuse (basal linear and basal laminar deposits) (3, 4).”
BackgroundOxidative stress promotes ocular neovascularization
Dong, A., Xie, B., Shen, J., Yoshida, T., Yokoi, K., Hackett, S. F., & Campochiaro, P. A. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21698 · Cited by 129
Tian, J., Ishibashi, K., Ishibashi, K., Reiser, K., Grebe, R., Biswal, S., Gehlbach, P., & Handa, J. T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504759102 · Cited by 127
Receptor for advanced glycation end products and age-related macular degeneration
Howes, K. A., Liu, Y., Dunaief, J. L., Milam, A., Frederick, J. M., Marks, A., & Baehr, W. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0404 · Cited by 131
“This article must therefore be marked " advertisement " in accordance with 18 U.S.C. §1734 solely to indicate this fact. events (including NFB nuclear localization) in neovascular membranes excised from patients with wet AMD.”
BackgroundInfluentialIRON TOXICITY AS A POTENTIAL FACTOR IN AMD
WONG, R. W., RICHA, D. C., HAHN, P., GREEN, W. R., & DUNAIEF, J. L. (2007) · Retina · doi:10.1097/iae.0b013e318074c290 · Cited by 131
The role of advanced glycation end products in retinal ageing and disease
Glenn, J. V., & Stitt, A. W. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.016 · Cited by 148
An, E., Lu, X., Flippin, J., Devaney, J. M., Halligan, B., Hoffman, E., Csaky, K., & Hathout, Y. (2006) · Journal of Proteome Research · doi:10.1021/pr060121j · Cited by 130
Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye
Sene, A., Chin-Yee, D., & Apte, R. S. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.10.005 · Cited by 130
Age-related macular degeneration and the immune response: implications for therapy
Nussenblatt, R. B., & Ferris, F. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.06.025 · Cited by 130
Protein Modifications by 4-Hydroxynonenal and 4-Hydroxyhexenal in Light-Exposed Rat Retina
Tanito, M., Elliott, M. H., Kotake, Y., & Anderson, R. E. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0672 · Cited by 127
Chen, H., Liu, B., Lukas, T. J., & Neufeld, A. H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002339 · Cited by 129
“Many laboratories studying the components of drusen have shown that drusen has a complex protein composition that includes immunoglobulins, activated complement components and complement regulators from the choroidal circulation [4–6], and lipids, intracellular proteins and cytosolic stress response proteins from RPE…”
BackgroundNita, M., Grzybowski, A. E., Ascaso, F. J., & Huerva, V. (2014) · Mediators of Inflammation · doi:10.1155/2014/930671 · Cited by 136
“Oxidized components of lipofuscin, that is, isolevuglandin, bis-retinoid pyrimidine A2E, and carboxyethylpyrrole protein (CEP), and its adducts (generated in blood as a result of CEP conjugation with circulating plasma albumin) are present in lipofuscin of RPE cells, in soft drusen, and in systemic circulation [37, 57…”
BackgroundInfluentialHigh concentration of zinc in sub-retinal pigment epithelial deposits
Lengyel, I., Flinn, J. M., Pető, T., Linkous, D. H., Cano, K., Bird, A. C., Lanzirotti, A., Frederickson, C. J., & van Kuijk, F. J. G. M. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2006.12.015 · Cited by 141
Novel roles for α-crystallins in retinal function and disease
Kannan, R., Sreekumar, P. G., & Hinton, D. R. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.06.001 · Cited by 131
Bhutto, I. A., Baba, T., Merges, C., Juriasinghani, V., McLeod, D. S., & Lutty, G. A. (2011) · British Journal of Ophthalmology · doi:10.1136/bjo.2010.199216 · Cited by 126
Wong, W. T., Kam, W., Cunningham, D., Harrington, M. W., Hammel, K., MEYERLE, C. B., Cukras, C. A., Chew, E. Y., Sadda, S. R., & Ferris, F. L. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5637 · Cited by 135
Pilgrim, M. G., Lengyel, I., Lanzirotti, A., Newville, M., Fearn, S., Emri, E., Knowles, J. C., Messinger, J. D., Read, R. W., Guidry, C., et al. (2017) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.16-21060 · Cited by 120
“Proteomic analysis of isolated human drusen also implicated circulating plasma as a protein source.(10) Regardless of source(s), it is important to understand what triggers the retention of lipids and proteins in the sub-RPE space.”
BackgroundDrusen in patient-derived hiPSC-RPE models of macular dystrophies
Galloway, C. A., Dalvi, S., Hung, S. S. C., MacDonald, L. A., Latchney, L. R., Wong, R. C. B., Guymer, R. H., Mackey, D. A., Williams, D. S., Chung, M. M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710430114 · Cited by 123
“ECM thickening could then potentially inhibit the flux of metabolic waste products by RPE cells and lead to development of sub-RPE deposits (drusen) (12).”
BackgroundRole of Oxidative Stress in Ocular Diseases: A Balancing Act
Shu, D. Y., Chaudhary, S., Cho, K., Lennikov, A., Miller, W. P., Thorn, D. C., Yang, M., & McKay, T. B. (2023) · Metabolites · doi:10.3390/metabo13020187 · Cited by 131
CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION—WHAT IS THE CAUSE?
Spaide, R. F., Armstrong, D., & Browne, R. W. (2003) · Retina · doi:10.1097/00006982-200310000-00001 · Cited by 136
Genetic variants in the complement system predisposing to age-related macular degeneration: A review
Schramm, E. C., Clark, S. J., Triebwasser, M. P., Raychaudhuri, S., Seddon, J. M., & Atkinson, J. P. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.032 · Cited by 121
“Drusen are extracellular deposits containing cellular debris, lipids and various protein components including a number from the innate immune system (Johnson et al., 2000; Mullins et al., 2000; Crabb et al., 2002; Anderson et al., 2010).”
BackgroundA comprehensive analysis of the expression of crystallins in mouse retina.
Xi, J.-H., Farjo, R. A., Yoshida, S., Kern, T. S., Swaroop, A., & Andley, U. P. (2003) · PubMed · Cited by 122
Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD
Hadziahmetovic, M., Dentchev, T., Song, Y., Haddad, N., He, X., Hahn, P., Pratico, D., Wen, R., Harris, Z. L., Lambris, J. D., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1472 · Cited by 121
Cruz-Guilloty, F., Saeed, A. M., Echegaray, J. J., Duffort, S., Ballmick, A., Tan, Y., Betancourt, M., Viteri, E., Ramkhellawan, G. C., Ewald, E., et al. (2013) · International Journal of Inflammation · doi:10.1155/2013/503725 · Cited by 117
“Identification of complement factor proteins in drusen from AMD eyes [7], coupled with genetic variation in several complement factor genes in AMD patients [8–13], collectively implicates inflammation as an important component in the pathophysiology of this disease [14, 15].”
BackgroundSelf-citationEvidence for an inflammatory process in age-related macular degeneration gains new support
Bok, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502819102 · Cited by 120
Complement factor H polymorphisms in Japanese population with age-related macular degeneration.
Okamoto, H., Umeda, S., Obazawa, M., MINAMI, M., Noda, T., Mizota, A., Honda, M., Tanaka, M., Koyama, R., Takagi, I., et al. (2006) · PubMed · Cited by 130
C3- and CR3-dependent microglial clearance protects photoreceptors in retinitis pigmentosa
Silverman, S. M., Ma, W., Wang, X., Zhao, L., & Wong, W. T. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20190009 · Cited by 119
“, 2002), as well as complement-laden deposits and increased complement activation (Mullins et al., 2000; Crabb et al., 2002).”
BackgroundAge-related macular degeneration and changes in the extracellular matrix
Romaniuk, W. (2014) · Medical Science Monitor · doi:10.12659/msm.889887 · Cited by 131
Wu, Z., Lauer, T. W., Sick, A., Hackett, S. F., & Campochiaro, P. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702321200 · Cited by 118
Inana, G., Murat, C., An, W., Yao, X., Harris, I. R., & Cao, J. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1434-6 · Cited by 114
Bazan, N. G. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0918 · Cited by 125
“Moreover, in drusen (deposits of debrislike material that accumulate between the RPE cells and Bruch’s membrane) from patients with AMD, DHA oxidation products have been found to form protein adducts.(87) Trauma or retinal detachment induces RPE dysfunctions that, in turn, contribute to the onset and development of pr…”
BackgroundMechanisms of Altered Redox Regulation in Neurodegenerative Diseases—Focus on S-Glutathionylation
Liedhegner, E. S., Gao, X., & Mieyal, J. J. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4119 · Cited by 127
“Clinical studies have suggested accumulation of CEP-protein adducts contribute to the pathogenesis of age-related macular degeneration (39).”
Wong, J. H. C., Jessica, Y. W., Jobling, A. I., Brandli, A. A., Greferath, U., Fletcher, E. L., & Vessey, K. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1009599 · Cited by 132
Ebrahem, Q., Renganathan, K., Sears, J., Vasanji, A., Gu, X., Lu, L., Salomon, R. G., Crabb, J. W., & Anand-Apte, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601552103 · Cited by 117
Self-citationPhagocyte dysfunction, tissue aging and degeneration
Li, W. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.05.006 · Cited by 118
Photodegradation of retinal bisretinoids in mouse models and implications for macular degeneration
Ueda, K., Zhao, J., Kim, H. J., & Sparrow, J. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524774113 · Cited by 114
Jun, S., Datta, S., Wang, L., Pegany, R. B., Cano, M., & Handa, J. T. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.09.023 · Cited by 127
Metadata
- Authors
- Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., Salomon, R. G., & Hollyfield, J. G.
- Affiliations
- Cleveland Clinic (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-10-21
- Volume
- 99
- Issue
- 23
- Pages
- 14682-14687
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC137479
- OpenAlex
- W2136501493
- Semantic Scholar
- 56777252bd03c9f9e59663891e03c8a458996b5f
- Cited by
- 1,208
- References
- 39
- Citations by year
- 2026: 30 · 2025: 40 · 2024: 35 · 2023: 39 · 2022: 52 · 2021: 56 · 2020: 49 · 2019: 34 · 2018: 65 · 2017: 62 · 2016: 44 · 2015: 56 · 2014: 73 · 2013: 57 · 2012: 69
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Foundation Fighting Blindness
- Cleveland Clinic
- Cleveland Clinic Foundation
- National Institutes of Health (5r01ey002362-23, EY06603)
- National Eye Institute (R56EY014240, EY014239, EY06603, EY 014240, F32EY006603, R01EY006603, R01EY014239, EY 02362, R01EY014240)
- National Institute of General Medical Sciences (R01GM021249, GM 21249)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- drusen, age-related macular degeneration, Bruch's membrane, retinal pigment epithelium, protein oxidation, carboxymethyllysine, vitronectin, clusterin, serum albumin, crystallins, drusen formation, AMD pathogenesis
- MeSH terms
- Aged, Aged, 80 and over, Aging, Choroid, Enzymes, Eye, Eye Proteins, Humans, Macular Degeneration, Middle Aged, Reference Values, Retina, Optic Disk Drusen, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.